Neurotech International Ltd News

Neurotech International Ltd: Notification of cessation of securities - NTI

Nov 20 15:06

Neurotech International Ltd: Results of Annual General Meeting

Nov 20 09:43

Neurotech International Ltd: 2024 AGM Chairman Address and Investor Presentation

Nov 20 05:15

Neurotech International Ltd: Positive Genomic Effects of NTI164 in PANDAS/PANS Patients

Nov 15 05:20

Neurotech International Ltd: New Scientific Publication Highlights Benefits of NTI164

Nov 12 09:19

Neurotech International Ltd: Proposed issue of securities - NTI

Nov 11 05:53

Neurotech International Ltd: Neurotech Appoints Dr Anthony Filippis as MD/CEO

Nov 11 05:27

Neurotech International Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 23 06:28

Neurotech International Ltd: Notice of Annual General Meeting/Proxy Form

Oct 16 14:44

Neurotech International Ltd: Becoming a substantial holder

Oct 8 17:18

Neurotech International Ltd: US FDA Response to Orphan Drug Request in PANDAS/PANS

Oct 4 06:52

Neurotech International Ltd: Upcoming Presentation of Rett Syndrome Clinical Data

Sep 24 07:12

Neurotech International Ltd: Change of Director's Interest Notice

Sep 20 16:25

Neurotech International Ltd: Notification regarding unquoted securities - NTI

Sep 20 16:22

Neurotech International Ltd: Notification of cessation of securities - NTI

Sep 18 14:53

Neurotech International Ltd: Secondary Trading Notice

Sep 18 14:35

Neurotech International Ltd: Notification regarding unquoted securities - NTI

Sep 18 14:10

Neurotech International Ltd: Application for quotation of securities - NTI

Sep 18 14:08

Neurotech International Ltd: Becoming a substantial holder

Sep 17 17:22

Neurotech International Ltd: Ceasing to be a substantial holder

Sep 17 17:21